Physician profile
Robert Dimick
NPI 1346212602
$2,613.17
in general payments reported to CMS, 2019-2025
11 companies · $1,592 in 2025
The $1,592 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $104 · 2022: $18.95 · 2023: $231 · 2024: $93.67 · 2025: $1,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,187 · Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,187.41 |
| Food and Beverage | $729.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,723.95 | 2023-2025 | Pivox Oblique Lateral Spinal System, Cd Horizon Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Cgg Medical INC | $559.00 | 2019 | |
| Medtronic USA, INC. | $103.96 | 2020 | |
| Abbott Laboratories | $49.44 | 2025 | Penta, Eterna |
| Novo Nordisk INC | $37.09 | 2025 | Wegovy |
| Astellas Pharma US INC | $28.07 | 2025 | Veozah |
| Djo, LLC | $27.32 | 2025 | Cmf |
| Organogenesis INC. | $25.89 | 2025 | Puraply Wound Matrix |
| Axsome Therapeutics, INC. | $25.10 | 2025 | Symbravo |
| Relievant Medsystems, INC. | $18.95 | 2022 | |
| Depuy Synthes Sales INC. | $14.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dimick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.